ATE403152T1 - Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe - Google Patents

Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe

Info

Publication number
ATE403152T1
ATE403152T1 AT01976048T AT01976048T ATE403152T1 AT E403152 T1 ATE403152 T1 AT E403152T1 AT 01976048 T AT01976048 T AT 01976048T AT 01976048 T AT01976048 T AT 01976048T AT E403152 T1 ATE403152 T1 AT E403152T1
Authority
AT
Austria
Prior art keywords
epitope
protein
parent
sequences
parent protein
Prior art date
Application number
AT01976048T
Other languages
English (en)
Inventor
Michael Lassen
Morten Breindahl
Original Assignee
Besst Test Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besst Test Aps filed Critical Besst Test Aps
Application granted granted Critical
Publication of ATE403152T1 publication Critical patent/ATE403152T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Peptides Or Proteins (AREA)
AT01976048T 2000-10-17 2001-10-12 Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe ATE403152T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001546 2000-10-17
US24213500P 2000-10-23 2000-10-23

Publications (1)

Publication Number Publication Date
ATE403152T1 true ATE403152T1 (de) 2008-08-15

Family

ID=8159792

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976048T ATE403152T1 (de) 2000-10-17 2001-10-12 Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe

Country Status (6)

Country Link
EP (2) EP1340085B1 (de)
AT (1) ATE403152T1 (de)
AU (1) AU2002210394A1 (de)
CA (1) CA2425380A1 (de)
DK (1) DK1340085T3 (de)
WO (1) WO2002032947A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101621100B1 (ko) 2007-03-30 2016-05-13 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 백신에 유용한 약독화 바이러스
DE102008028295A1 (de) * 2008-06-13 2009-12-17 Engler, Jörg Mittel zur direkten Detektion von Borrelia bugdorferi sensu lato in Arthropoden vor Ort (ohne Labor)
WO2015134938A1 (en) 2014-03-07 2015-09-11 The Regents Of The University Of California Devices for integrating analyte extraction, concentration and detection
CA3002020C (en) 2015-09-04 2024-02-27 The Regents Of The University Of California Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
EP3469365B1 (de) 2016-06-09 2022-12-07 The Regents of the University of California Biomarkerkonzentration und signalverstärkung zur verwendung bei immunoassays auf papierbasis
WO2018039139A1 (en) 2016-08-22 2018-03-01 The Regents Of The University Of California Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection
WO2018183211A1 (en) 2017-03-27 2018-10-04 The Regents Of The University Of California Semi-quantitative lateral-flow immunoassay for the detection of csf leaks
CN116121103B (zh) * 2022-09-16 2024-09-27 中国烟草总公司郑州烟草研究院 一株解淀粉芽孢杆菌及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL194804B1 (pl) * 1998-03-16 2007-07-31 Alk Abello As Zrekombinowany alergen, sposób przygotowywania zrekombinowanego alergenu, kompozycja farmaceutyczna oraz zastosowanie zrekombinowanego alergenu do przygotowywania leku do wywoływania odpowiedzi immunologicznej u osobnika i do przygotowywania leku do leczenia, zapobiegania lub osłabiania reakcji alergicznych
ES2220114T3 (es) * 1998-10-30 2004-12-01 Novozymes A/S Variantes de proteinas poco alergenicas.
US20020009452A1 (en) * 1999-02-10 2002-01-24 Michael Caplan Method for altering undesirable immune responses to polypeptides
AU3717600A (en) * 1999-03-02 2000-09-21 Board Of Trustees Of The University Of Arkansas, The Methods and reagents for decreasing clinical reaction to allergy

Also Published As

Publication number Publication date
AU2002210394A1 (en) 2002-04-29
EP1328544A1 (de) 2003-07-23
CA2425380A1 (en) 2002-04-25
WO2002032947A1 (en) 2002-04-25
EP1340085A1 (de) 2003-09-03
EP1340085B1 (de) 2008-07-30
DK1340085T3 (da) 2008-12-01

Similar Documents

Publication Publication Date Title
WO2001083559A3 (en) Production and use of protein variants having modified immunogenecity
WO2000026230A8 (en) Low allergenic protein variants
JP2004504001A (ja) スプライソソーム媒介ｒｎａトランスースプライシングにおける使用のための方法及び組成物
WO2003074676A3 (en) Wax ester synthase dna sequence, protein and uses thereof
DE69829976D1 (de) Verfahren zur trocknung von kompetenten zellen
ATE547528T1 (de) Eine neue gruppe von alpha-amylasen sowie ein verfahren zur identifizierung und gewinnung neuer alpha-amylasen
ATE521695T1 (de) Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie
ATE353952T1 (de) Desaturasen und verfahren ihrer anwendung zur synthese von mehrfach ungesättigten fettsäuren
PL415463A1 (pl) Wyizolowany kwas nukleinowy, ssaczy wektor ekspresyjny, fuzje polipeptydowe, komórki gospodarza, sposób wytwarzania fuzji polipeptydowych, sposoby in vitro i ex vivo modyfikowania profilu glikozylacji, wyizolowana cząsteczka kwasu nukleinowego
WO2006124644A3 (en) Protein and antibody profiling using small molecule microarrays
ATE393237T1 (de) Mittel und verfahren zur in-vitro-bestimmung von camp
ATE403152T1 (de) Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe
DE602004028724D1 (de) Verfahren zur herstellung sezernierter polypeptide
ATE320484T1 (de) Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung
ATE498013T1 (de) Für zellzyklusproteine kodierende nukleinsäure und deren verwendung
DE60333486D1 (de) Fluoreszenzproteine aus copepoda-spezies und verfahren zur verwendung davon
DE50007565D1 (de) Verfahren zum transfer von molekularen substanzen mit prokaryontischen nukleinsaure-bindenden proteinen
WO2001064913A3 (en) Cell cycle proteins associated with rad9, compositions and methods of use
WO1998054212A3 (de) Das protein des humanen ryanodinrezeptors vom typ 3 sowie dafür kodierende dna-moleküle
WO2002029057A3 (en) 32144, a human fatty acid amide hydrolase and uses thereof
WO2006126068A3 (en) Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia
WO2003062378A3 (en) Methods of random mutagenesis and methods of modifying nucleic acids using translesion dna polymerases
WO2001030987A3 (en) Tankyrase h, compositions involved in the cell cycle and methods of use
ATE290549T1 (de) Ing2, ein mit iaps assoziiertes zellzyklusprotein,sowie zusammensetzungen, verfahren und verwendungen
DE60233347D1 (de) Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties